Chris Dall | News Reporter | CIDRAP NewsJun 11, 2020Also, the NIH said researchers will begin assessing antiviral and anti-inflammatory drugs in children.
Regeneron to begin trials for COVID-19 antibody cocktail
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Vaccinated kids at 57% to 73% lower risk of long COVID, CDC study suggests
- More than half of COVID-19 ECMO patients die in hospital, while survivors often struggle long term, study finds
- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
- ACIP postponement, shelving of CDC vaccine campaigns stir fears